Repeated-Dose 28-Day Oral Toxicity Study of a Salmonella enterica Serovar Typhimurium Bacteriophage Cocktail (SE.PC) in BALB/c Mice
PHAGE: Therapy, Applications, and Research · 01.09.2026 · 7 (3) · 178-186
DOI: 10.1177/26416549261448405 ↗Kurz gefasst
Fachartikel in der Zeitschrift PHAGE: Therapy, Applications, and Research, online erschienen am 02.05.2026. Verfasst von Yee Fan Tan und 4 weiteren Autor:innen. Beteiligte Einrichtung: Center of Excellence for Omics-Driven Computational Biodiscovery (COMBio), AIMST University, Bedong, Kedah, Malaysia. Die Arbeit nennt 43 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Fundamental Research Grant Scheme (FRGS) from the Ministry of Education (MOE) of Malaysia.
Abstract (Originalsprache)
Background
Phage therapy is a promising alternative for drug-resistant Salmonella , but safety data for repeated doses are limited. This study investigated the sub-chronic safety of SE.PC, a candidate Salmonella enterica serovar Typhimurium phage cocktail, in a non-specific pathogen-free (non-SPF) model, which contains a naturally occurring microbiota, to evaluate systemic safety under physiologically relevant conditions. We tested a range of phage doses to determine if there are any differences in tolerance. Materials and Methods: During a 28-day repeated-dose oral toxicity study, SE.PC was administered via weekly gavage to male and female non-SPF BALB/c mice across three different phage doses (2.43 × 10 9 , 4.85 × 10 9 , and 9.70 × 10 9 plaque-forming units/mL). Clinical signs, body weight, hematology, biochemistry, and histopathology were assessed.
Results
Across all three administered phage dose groups, no mortality was recorded, and all mice exhibited normal clinical signs and growth. Hematological and biochemical values remained within baseline ranges. Histopathology revealed no treatment-related lesions; isolated findings were deemed incidental or adaptive.
Conclusion
Evidence supports that SE.PC is well tolerated. This study demonstrates a strong safety profile, supporting the advancement of SE.PC as a biocontrol agent.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Center of Excellence for Omics-Driven Computational Biodiscovery (COMBio), AIMST University, Bedong, Kedah, Malaysia.
- Center for Evolutionary Hologenomics, Globe Institute, University of Copenhagen, Copenhagen, Denmark.
- Pharmacology, Toxicology, and Basic Health Sciences Unit, AIMST University, Bedong, Kedah, Malaysia.
ORCID-Profile: Yee Fan Tan
Förderung
- Fundamental Research Grant Scheme (FRGS) from the Ministry of Education (MOE) of Malaysia
Zitieren
APA
Tan, Y. F., Mutusamy, P., Parimannan, S., Rajandas, H., & Subramani, P. (2026). Repeated-Dose 28-Day Oral Toxicity Study of a Salmonella enterica Serovar Typhimurium Bacteriophage Cocktail (SE.PC) in BALB/c Mice. PHAGE: Therapy, Applications, and Research, 7(3), 178-186. https://doi.org/10.1177/26416549261448405
Vancouver
Tan YF, Mutusamy P, Parimannan S, Rajandas H, Subramani P. Repeated-Dose 28-Day Oral Toxicity Study of a Salmonella enterica Serovar Typhimurium Bacteriophage Cocktail (SE.PC) in BALB/c Mice. PHAGE: Therapy, Applications, and Research. 2026;7(3):178-186. doi:10.1177/26416549261448405
BibTeX
@article{Tan2026,
author = {Tan, Yee Fan and Mutusamy, Prasanna and Parimannan, Sivachandran and Rajandas, Heera and Subramani, Parasuraman},
title = {Repeated-Dose 28-Day Oral Toxicity Study of a Salmonella enterica Serovar Typhimurium Bacteriophage Cocktail (SE.PC) in BALB/c Mice},
journal = {PHAGE: Therapy, Applications, and Research},
year = {2026},
volume = {7},
number = {3},
pages = {178--186},
doi = {10.1177/26416549261448405}
}
EUVIMED